Methoxsalen sterile solution in conjunction with photopheresis system as an interventional therapy for the treatment of CTCL (mycosis fungoides) in patients with TMN classification Stage IA, IB, or IIA

This study is investigating the use of methoxsalen sterile solution in conjunction with photopheresis system as an interventional therapy for the treatment of CTCL (mycosis fungoides) in patients with TMN classification Stage IA, IB, or IIA.

You may be eligible to participate in this study if you:

• Weigh more than 88 pounds
• Have adequate veins for intravenous access
• Are not using any other investigational device or on any other investigational treatment
• Are not pregnant or lactating and do not have the potential to become pregnant

This is a partial list of eligibility requirements. For specific information about your eligibility, call the number provided.